|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/117 | (2010.01) |
| A61K 31/7125 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 3947685 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20760858.9 |
| Date of filing the European patent application | 2020-08-21 | |
| (97) | Date of publication of the European application | 2022-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-13 |
| (46) | Date of publication of the claims translation | 2022-08-25 |
| (86) | Number | PCT/EP2020/073566 |
| Date | 2020-08-21 |
| (87) | Number | WO 2021/037764 |
| Date | 2021-03-04 |
| (30) | Number | Date | Country code |
| 201912191 | 2019-08-24 | GB |
| (72) |
ZERHOUNI, Peter , SE
SANDWALL, Pernilla , SE
KNITTEL, Thomas , SE
|
| (73) |
InDex Pharmaceuticals AB ,
Berzelius väg 13, 171 65 Solna,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Oligonukleotido panaudojimu grindžiama opinio kolito terapija |
| OLIGONUCLEOTIDE-BASED THERAPY FOR ULCERATIVE COLITIS |
| Payment date | Validity (years) | Amount | |
| 2023-06-22 | 4 | 92.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-21 |